Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) Short Interest Update

Sigyn Therapeutics, Inc. (OTCMKTS:SIGYGet Rating) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 3,800 shares, a growth of 35.7% from the April 15th total of 2,800 shares. Based on an average daily trading volume, of 800 shares, the short-interest ratio is presently 4.8 days.

SIGY opened at $0.34 on Wednesday. Sigyn Therapeutics has a one year low of $0.17 and a one year high of $1.36. The stock’s fifty day moving average is $0.35 and its 200-day moving average is $0.48.

About Sigyn Therapeutics (Get Rating)

Sigyn Therapeutics, Inc operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address CytoVesicles that transport inflammatory cytokine cargos throughout the bloodstream.

Further Reading

Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.